Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells is Reduced by HMG-CoA Reductase Inhibitor, Pravastatin.

MIYASHITA Y; OZAKI H; KOIDE N; OTSUKA M; OYAMA T; ITOH Y; MASTUZAKA T; SHIRA IK

Art

J-GLOBAL ID：200902154155084773 Reference number：02A0270715

Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells is Reduced by HMG-CoA Reductase Inhibitor, Pravastatin.

オキシステロールで誘導される血管平滑筋細胞のアポトーシスはHMG-CoA還元酵素阻害剤プラバスタチンで抑制される

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=02A0270715&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0270715&from=J-GLOBAL&jstjournalNo=L2187A") }}

Author (8)： , , , , , , ,
Material：
Volume： 9 Issue： 1 Page： 65-71 Publication year： 2002
JST Material Number： L2187A ISSN： 1340-3478 CODEN： JATHEH Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0270715&from=J-GLOBAL&jstjournalNo=L2187A") }}

Basic research of drugs acting on lipid metabolism

, ,

Reference (34)：

(1) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, and Packard CJ: Prevention of corony heart disease with pravastatin in men with hypercholesterolemia. N Engl J MED, 333: 1301-1307, 1995
(2) Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, and McGovern ME: Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-1): reduction in atherosclerosis progression and clinical events. PLAC-1 investigation. J Am Coll Cardiol, 26: 1133-1139, 1995
(3) Byington RP, Furberg CD, Crouse JR 3rd, Espeland MA, and Bond MG: Pravastatin, Lipids, and atherosclerosis in the catotid arteries (PLAC-II). Am J Cardiol, 76: 54C-59C, 1995
(4) Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Belder R, Park JS, and Salonen JT: Kupio atherosclerosis prevention study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation, 92: 1758-1764, 1995
(5) Gaw A: Can the clinical efficacy of the HMG CoA reductase inhibitors be explained solely by their effects on LDL-cholesterol ?. Atherosclerosis, 125: 267-269, 1996

ｍore...

, , , , ,

Return to Previous Page